Forgive the new thread but it might be time to have a dedicated place for those Analyst snapshots that members post and are generally quite informative, but also Finance and even News media relating to Neuren's progress and prospects. The aim is to have a collation rather than scanning multiple threads as pieces get placed here or there.
Here's one, it might have been posted elsewhere:
https://**promotion blocked**/health/neurens-stock-price-doubles-on-groundbreaking-drug-trial-ceo-says-its-just-getting-started/
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.10 |
Change
-0.800(5.76%) |
Mkt cap ! $1.629B | |||
| Open | High | Low | Value | Volume |
| $13.95 | $13.96 | $12.88 | $9.534M | 725.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 266 | $13.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.15 | 1619 | 2 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |